Article

Coronary artery bypass in idiopathic thrombocytopenia without splenectomy.

Department of Surgery, Walter Reed Army Medical Center, Washington, DC 20307-5001.
The Annals of Thoracic Surgery (Impact Factor: 3.45). 12/1989; 48(5):721-2. DOI: 10.1016/0003-4975(89)90804-7
Source: PubMed

ABSTRACT A patient with coronary artery disease and idiopathic thrombocytopenia purpura underwent coronary artery bypass grafting without splenectomy. Our experience indicates that use of cardiopulmonary bypass in patients with idiopathic thrombocytopenic purpura does not invariably mandate splenectomy.

1 Bookmark
 · 
55 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The association of cyanotic heart disease with Idiopathic Thrombocytopenic Purpura (ITP) may accentuate the hemorrhagic complications of cardiac surgery under cardiopulmonary bypass. A-5-year-old girl with Chronic Steroid Refractory Idiopathic Thrombocytopenic Purpura with Tetralogy of Fallot (TOF) underwent successful intracardiac repair under normothermic cardiopulmonary bypass and warm blood potassium cardioplegia. Presurgery she received immunoglobulins and perioperatively she was administered inj methylprednisolone, inj aprotinin, platelets and fresh frozen plasma.
    Indian Journal of Thoracic and Cardiovascular Surgery 01/2007; 23(2):159-160.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Immune thrombocytopenia (ITP) is no longer a disorder of young people. Half of the patients are older than 50 and comorbidities become more common with age. Anticoagulation has to be discussed when an ITP patient develops atrial fibrillation, venous or arterial thromboembolism, myocardial infarction, or stroke. At the same time low platelet counts often prohibit therapeutic anticoagulation. Guidelines do not give guidance for these situations. This article summarizes experiences from case reports and small series and suggests an approach to ITP patients with thrombocytopenia and an indication for anticoagulation.
    Seminars in Hematology 01/2013; 50 Suppl 1:S83-8. · 3.36 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Der Stellenwert des Morbus Werlhof (idiopathische thrombozytopenische Purpura) bei Patienten, die sich einem herzchirurgischen Eingriff mit Hilfe der Herz-Lungen-Maschine, unterziehen, ist bislang weitgehend unbekannt. Wir berichten über drei Patienten, bei denen wir eine aortokoronare Bypass-Operation (bei einem Patienten zusätzlich mit einer Carotisdesobliteration) nach einer präoperativen Vorbehandlung mit Immunglobulinpräparaten durchführten. Zwei Patienten hatten einen unkomplizierten perioperativen Verlauf, ein Patient starb infolge einer ventrikulären Rhythmusstörung. Die Fallbeispiele zeigen, daß herzchirurgische Eingriffe bei Patienten mit Morbus Werlhof nach präoperativer Immunglobulintherapie mit akzeptablem Risiko durchgeführt werden können. The operative risk for patients suffering from Werlhof’s disease (idiopathic thrombocytopenic purpura) and undergoing cardiac surgery with cardiopulmonary bypass is not known until now. We report on three patients undergoing coronary artery bypass grafting (combined in one patient with thromboendarterectomy of the internal carotid artery) after preoperative treatment with immunoglobulins. Two patients had an uncomplicated perioperative course. One patient died because of ventricular arrhythmias. These case reports demonstrate that cardiac surgery in patients suffering from Werlhof’s disease can be carried out with an acceptable risk after preoperative treatment with immunoglobulins.
    Zeitschrift für Herz- Thorax- und Gefäßchirurgie 01/1997; 11(4):198-202.